# New York Blood Center Enterprises, Long Island City, NY – FDA Inspections

Source: https://www.keypedia.com/companies/new-york-blood-center-enterprises/29bd2008-0b6c-4674-90f5-96ad1caea4db

> Inspection records and compliance data for New York Blood Center Enterprises in Long Island City, New York. 14 FDA inspections on record, 5 Form 483s, last inspected April 03, 2026.

---

## Details

- Name: New York Blood Center Enterprises
- FEI Number: 2473015
- Address Line 1: 4501 Vernon Blvd
- City: Long Island City
- State: New York
- Zip Code: 11101
- Country Name: United States
- Address: 4501 Vernon Blvd, Long Island City, New York 11101, United States
- Country: United States

## Related Documents

- [483 - New York Blood Center Enterprises - Unknown Date](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/eed1c575-459e-4f2d-b827-52aeb89623d1) — source: FDA, date: Invalid Date
- [483 - New York Blood Center Enterprises - 2026-04-03](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/5c23488f-946d-4bc2-81bf-230ed61f964f) — source: FDA, date: April 3, 2026
- [FDA Inspection 1311062 - New York Blood Center Enterprises - 2026-04-03](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/044a9fd6-4493-4d21-a1cf-9c768fb3add1) — source: FDA, date: April 3, 2026
- [FDA Inspection 1283668 - New York Blood Center Enterprises - 2025-09-24](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/91ecba89-ae8a-4854-a2eb-f3ceac565d66) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 24, 2025
- FDA Inspection 1217513 - New York Blood Center Enterprises - 2023-09-07 — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023
- FDA Inspection 1217513 - New York Blood Center Enterprises - 2023-09-07 — classification: No Action Indicated (NAI), source: FDA, date: September 7, 2023
- [483 - New York Blood Center Enterprises - 2020-02-11](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/3e5035ef-b0ef-43ea-b48b-39547a2005ad) — source: FDA, date: February 11, 2020
- [FDA Inspection 1118178 - New York Blood Center Enterprises - 2020-02-11](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/d7c05152-a755-44b7-acb6-8b9840cbb679) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 11, 2020
- FDA Inspection 1064704 - New York Blood Center Enterprises - 2018-08-07 — classification: No Action Indicated (NAI), source: FDA, date: August 7, 2018
- [FDA Inspection 1036848 - New York Blood Center Enterprises - 2017-11-22](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/c5d0fa69-163e-462a-83c2-e34a55cd287b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2017
- [483 - New York Blood Center Enterprises - 2017-09-29](https://www.keypedia.com/records/483/new-york-blood-center-enterprises/89e4ed87-8aee-4226-bc00-c4c265fec5a4) — source: FDA, date: September 29, 2017
- [FDA Inspection 1027270 - New York Blood Center Enterprises - 2017-09-29](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/019b559d-7299-43c7-bebb-75f4f7aae907) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2017
- [FDA Inspection 1000172 - New York Blood Center Enterprises - 2017-01-25](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/e7e18843-c680-4f85-a98b-cc2fc8688833) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2017
- [FDA Inspection 945089 - New York Blood Center Enterprises - 2015-09-30](https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/b0dbe26c-0ead-42e8-af81-3d11ba9acb49) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 30, 2015

## Related Companies

- [Ferring Microbiome Inc.](https://www.keypedia.com/companies/ferring-microbiome-inc/860d4130-d93a-4017-97ca-30033280de85)
- [Henogen SRL](https://www.keypedia.com/companies/henogen-srl/273669c2-3349-41d3-a904-a56d90f76482)
- [OMRIX Biopharmaceuticals LTD](https://www.keypedia.com/companies/omrix-biopharmaceuticals-ltd/bf1b8f1e-b1c7-47be-bb38-f85e1cff944d)
- [Baxalta Belgium Manufacturing SA](https://www.keypedia.com/companies/baxalta-belgium-manufacturing-sa/61b3acce-a147-4f22-b13a-34bb436ea8e9)
- [Baxalta US Inc.](https://www.keypedia.com/companies/baxalta-us-inc/dd00e45b-9175-4b17-82d5-b189a034a97f)
- [Duke Medical Center-Carolinas Cord Blood Bank and Stem Cell Laboratory](https://www.keypedia.com/companies/duke-medical-center-carolinas-cord-blood-bank-and-stem-cell-laboratory/c0d3517e-a147-4272-aa62-323feeca0e0b)
- [Minaris Regenerative Medicine, LLC](https://www.keypedia.com/companies/minaris-regenerative-medicine-llc/b5fdb186-e2e7-416c-b89e-66d15dbf5509)
- [Burgwedel Biotech GmbH](https://www.keypedia.com/companies/burgwedel-biotech-gmbh/0e5bd74d-d86f-477b-a3d7-cb7865573df9)
- [AstraZeneca Pharmaceuticals LP](https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/f969afa9-62d8-4cde-8873-48180823df9b)
- [Octapharma Pharmazeutika Produktionsgesellschaft m.b.H.](https://www.keypedia.com/companies/octapharma-pharmazeutika-produktionsgesellschaft-mbh/36184852-dad7-4350-8b6f-36d4527ba46f)

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)
- [investigator](https://www.keypedia.com/people/jacqueline-m-diaz-albertini/9ff937fe-4e9b-445a-80fa-e26800d923b8)
- [Investigator](https://www.keypedia.com/people/burnell-m-henry/dece4407-3597-4a58-8756-5abf9db43bbc)
